Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4/A Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
  5. 4/A Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
  6. 4/A Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
  7. 4/A Open-market buy CEO bought 4,500 shares at an average $0.80 ($3,611)
  8. 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
  9. 4 Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
  10. 4 Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
  11. 4 Open-market buy CEO bought 4,600 shares at an average $0.80 ($3,696)
  12. 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
  13. 4 Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
  14. 4 Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
  15. 4 Open-market buy CEO bought 4,600 shares at an average $0.80 ($3,696)
  16. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Controller sold 11,333 shares at $1.00 ($11,333)

Page 13 of 18 · 341 filings